logo
Select company
Select metric
$ 1.84MNet Cash Flow - Financing
VS
Market
43
Sector
61
Industry
71
History
62
$ 51.36Close
$ 10.8 - $ 80.04 52-Week Range
Ticker Information

Ticker

KRRO

Company Name

KORRO BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KORRO BIO INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KRRO - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 1.84M
3/31/2025$ 69.39M
12/31/2024$ 69.36M
9/30/2024$ 270.32M
6/30/2024$ 269.59M
3/31/2024$ 190.37M
12/31/2023$ 187.76M
9/30/2023$ -14.97M
6/30/2023$ -14.91M
3/31/2023$ -3.25M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KORRO BIO INC's latest trailing twelve months (TTM) CF - Financing stands at $ 123.5M.
  • Over the past 5 years, KORRO BIO INC's average CF - Financing has been $ 66.95M.
  • The median CF - Financing for KORRO BIO INC during this period was $ 36.66M
  • KORRO BIO INC reached its highest CF - Financing over the past 5 years at $ 270.32M.
  • The lowest CF - Financing recorded by KORRO BIO INC in the same timeframe $ -14.97M

KORRO BIO INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
CRBU : CARIBOU BIOSCIENCES INC $ 4.58MACOG : ALPHA COGNITION INC $ 50.43MTCRX : TSCAN THERAPEUTICS INC $ 46.51MTVRD : TVARDI THERAPEUTICS INC $ 20.71MOBIO : ORCHESTRA BIOMED HOLDINGS INC $ 28.26MFATE : FATE THERAPEUTICS INC $ 4.46MCRVO : CERVOMED INC $ -13.34KOVID : OVID THERAPEUTICS INC $ 51KCBUS : CIBUS INC $ 60.18MARMP : ARMATA PHARMACEUTICALS INC $ 9.93M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

KRRO - Net Cash Flow - Financing, Last 5 years

$ -14.97M

Minimum

Sep 30, 2023

$ 270.32M

Maximum

Sep 30, 2024

$ 66.95M

Average

$ 36.66M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.94M with a standard deviation of $ 118.72M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -365.75M
max$ 365M
average$ -6.94M
median$ 305.91K
std$ 118.72M